Statins and cognition in late-life bipolar disorder

被引:4
|
作者
Rej, Soham [1 ,2 ,3 ]
Schulte, Sarah Waters [1 ,2 ]
Rajji, Tarek K. [1 ,2 ]
Gildengers, Ariel G. [4 ]
Miranda, Dielle [1 ,2 ]
Menon, Mahesh [5 ]
Butters, Meryl A. [4 ]
Mulsant, Benoit H. [1 ,2 ]
机构
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada
[3] McGill Univ, Jewish Gen Hosp, Dept Psychiat, Montreal, PQ, Canada
[4] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[5] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
bipolar disorder; cognition; mood disorders; statins; OLDER-ADULTS; RATING-SCALE; INSTRUMENTAL ACTIVITIES; DEPRESSION; RISK; NEUROPROGRESSION; INDIVIDUALS; VALIDITY; DECLINE; PEOPLE;
D O I
10.1002/gps.4956
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
ObjectivesRecent data suggests that statins have positive effects on cognition in older adults. Studies in patients with mood disorders have found contradicting positive and negative effects of statins on mood and cognition, with limited data in bipolar disorder (BD). The objective of this study was to assess the association between statin use and cognition in older adults with BD. MethodsIn a cross-sectional sample of 143 euthymic older adults with BD (age50), statin users (n=48) and nonusers (n=95) were compared for cognitive outcomes: Global and cognitive domain z-scores were calculated from detailed neuropsychological batteries using normative data from healthy comparators (n=87). ResultsThe sample had a mean age of 64.3 (8.9) years, 65.0% were female, with an average of 15.1 (+/- 2.79) years of education. Statin users did not differ from nonusers on global (-0.60 [+/- 0.69] vs -0.49 [+/- 0.68], t[127]=0.80, P=.42) or individual cognitive domains z-score. ConclusionsIn older patients with BD, statin use is not independently associated with cognitive impairment. This suggests that in older BD patients, the cognitive dysfunction associated with BD trumps the potential cognitive benefit that is associated with statins in older adults without a psychiatric disorder. Further, statins do not seem to exacerbate this cognitive dysfunction. Future longitudinal studies are needed to confirm these findings.
引用
收藏
页码:1355 / 1360
页数:6
相关论文
共 50 条
  • [41] Anxiety in late-life depression: Associations with brain volume, amyloid beta, white matter lesions, cognition, and functional ability
    Kryza-Lacombe, Maria
    Kassel, Michelle T.
    Insel, Philip S.
    Rhodes, Emma
    Bickford, David
    Burns, Emily
    Butters, Meryl A.
    Tosun, Duygu
    Aisen, Paul
    Raman, Rema
    Landau, Susan
    Saykin, Andrew J.
    Toga, Arthur W.
    Jack, Clifford R.
    Koeppe, Robert
    Weiner, Michael W.
    Nelson, Craig
    Mackin, R. Scott
    INTERNATIONAL PSYCHOGERIATRICS, 2024, 36 (11) : 1009 - 1020
  • [42] The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults
    Gildengers, Ariel G.
    Mulsant, Benoit H.
    Al Jurdi, Rayan K.
    Beyer, John L.
    Greenberg, Rebecca L.
    Gyulai, Laszlo
    Moberg, Paul J.
    Sajatovic, Martha
    Ten Have, Thomas
    Young, Robert C.
    BIPOLAR DISORDERS, 2010, 12 (08) : 851 - 858
  • [43] Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression
    Gandelman, Jason A.
    Newhouse, Paul
    Taylor, Warren D.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2018, 84 : 289 - 298
  • [44] Dual-tasking gait variability and cognition in late-life depression
    Gabel, Nicolette M.
    Crane, Natania A.
    Avery, Erich T.
    Kay, Rachel E.
    Laurent, Amanda
    Giordani, Bruno
    Alexander, Neil B.
    Weisenbach, Sara L.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (11) : 1120 - 1128
  • [45] Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life
    Anaya, C.
    Torrent, C.
    Caballero, F. F.
    Vieta, E.
    del Mar Bonnin, C.
    Ayuso-Mateos, J. L.
    ACTA PSYCHIATRICA SCANDINAVICA, 2016, 133 (05) : 386 - 398
  • [46] Tryptophan breakdown and cognition in bipolar disorder
    Platzer, Martina
    Dalkner, Nina
    Fellendorf, Frederike T.
    Birner, Armin
    Bengesser, Susanne A.
    Queissner, Robert
    Kainzbauer, Nora
    Pilz, Rene
    Herzog-Eberhard, Simone
    Hamm, Carlo
    Hoermanseder, Christa
    Maget, Alexander
    Rauch, Philipp
    Mangge, Harald
    Fuchs, Dietmar
    Zelzer, Sieglinde
    Schuetze, Gregor
    Moll, Natalie
    Schwarz, Markus J.
    Mansur, Rodrigo B.
    McIntyre, Roger S.
    Reininghaus, Eva Z.
    PSYCHONEUROENDOCRINOLOGY, 2017, 81 : 144 - 150
  • [47] Neuropsychological Predictors of Dementia in Late-Life Major Depressive Disorder
    Potter, Guy G.
    Wagner, H. Ryan
    Burke, James R.
    Plassman, Brenda L.
    Welsh-Bohmer, Kathleen A.
    Steffens, David C.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 21 (03) : 297 - 306
  • [48] Brain structural changes in late-life generalized anxiety disorder
    Andreescu, Carmen
    Tudorascu, Dana
    Sheu, Lei K.
    Rangarajan, Anusha
    Butters, Meryl A.
    Walker, Sarah
    Berta, Rachel
    Desmidt, Thomas
    Aizenstein, Howard
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2017, 268 : 15 - 21
  • [49] Pramipexole to Improve Cognition in Bipolar Disorder A Randomized Controlled Trial
    Van Meter, Anna R.
    Perez-Rodriguez, M. Mercedes
    Braga, Raphael J.
    Shanahan, Megan
    Hanna, Lauren
    Malhotra, Anil K.
    Burdick, Katherine E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (04) : 421 - 427
  • [50] Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care
    Sajatovic, Martha
    Forester, Brent P.
    Gildengers, Ariel
    Mulsant, Benoit H.
    NEUROPSYCHIATRY, 2013, 3 (06) : 621 - 633